Ashwin Kishtagari

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Ashwin Kishtagari
Jan 4, 2025, 15:27 | Science
Ashwin Kishtagari: How non-selective β-blockers impair hematopoietic regeneration after HCT
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X about a…
Dec 19, 2024, 07:41 | Blog
IMPACT Malignant Hematology Webinar on the evolving treatment landscape of lower-risk MDS - Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center shared on X: “Join Dr. Ashwin Kishtagari, Assistant Professor of Medicine, on…
Dec 11, 2024, 17:22 | Blog
Ashwin Kishtagari: Brilliant ASH24 E. Donnall Thomas Lecture by Sean Morrison on HSC maintenance
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared on X: “Brilliant ASH24 E. Donnall…
Oct 17, 2024, 17:25 | Blog
Ashwin Kishtagari: A fantastic visit to Cleveland Clinic Translational Hematology and Oncology Research program
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X: ''Had a…
Oct 16, 2024, 11:41 | Insight
Highlights from the 2024 Summit on Haematological Cancers by The Binaytara Foundation
The 2024 Summit on Haematological Cancers by The Binaytara Foundation took place at the Hutton…
Oct 14, 2024, 15:52 | Blog
Ashwin Kishtagari: Naveen Pemmaraju explores the potential of novel JAK inhibitors in myelofibrosis
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared on X: '' Naveen Pemmaraju explores…
Jul 15, 2024, 21:23 | Insight
Zhuoer Xie: Risk Prediction for Clonal Cytopenia
Zhuoer (Zoey) Xie, Hematologist at Moffitt Cancer Center, shared on X about a recent paper…
Jul 15, 2024, 21:23 | Insight
Herculean effort on risk prediction model for clonal cytopenias
UChicago Leukemia Program shared a post on X about a recent paper by Zhuoer Xie et…
May 12, 2024, 01:40 | Insight
Justin Watts: A significant portion of patients at the extremes of older age (80-90) still derive benefit from the VEN-HMA regimen
Justin Watts et al. report that standard of care treatment for acute myeloid leukemia extends…
Apr 11, 2024, 13:56 | Blog
Ashwin Kishtagari: A case with distinct bone marrow findings associated with a noncanonical UBA1 variant
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X/Twitter: "We report a…
Mar 26, 2024, 09:53 | Blog
Manni Mohyuddin: Dr. Tefferi's advice is so REFRESHING and AUTHENTIC
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, recently posted on…
Jan 19, 2024, 18:33 | Blog
Ashwin Kishtagari: CHIP mutation zygosity and risk to hematologic malignancies
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X/Twitter: "Happy to share…
All: 12 Posts: 1 - 100
Special Coverage